BusinessInnocoll Announces Top-Line Data From Phase 3 Trials With COGENZIA and NDA Submission for XARACOLLBy Nasdaq OMXNov 3, 2016, 8:31 PM UTC
BusinessMerus Strengthens Executive Management Team with the Appointment of John Crowley as Chief Financial OfficerBy Nasdaq OMXNov 3, 2016, 11:00 AM UTC
BusinessWright Medical Group N.V. Reports 2016 Third Quarter Financial Results and Updates 2016 GuidanceBy Nasdaq OMXNov 2, 2016, 8:05 PM UTC
BusinessEntia Biosciences, Inc. (OTCQB: ERGO) Receives Notification of the Grant of European Patent it has Exclusively Licensed for Identifying the Ergothioneine Transporter and its Therapeutic UsesBy Nasdaq OMXNov 2, 2016, 7:20 PM UTC
BusinessZynerba Pharmaceuticals Announces Initiation of STAR 2 Open-Label Extension Clinical Trial for ZYN002 CBD Gel in Adult Refractory Epilepsy PatientsBy Nasdaq OMXNov 2, 2016, 11:01 AM UTC
BusinessApricus Biosciences Announces Corporate Update and Third Quarter 2016 Financial Results Conference CallBy Nasdaq OMXNov 2, 2016, 11:00 AM UTC
